TP53 and breast cancer: Germline variants of the form p.R181C were found to be a founder mutation associated with an increased risk of breast cancer in Arab families and is the only p53 variant that can be identified in a situation of homozygosity, suggesting a low penetrance associated with a partial loss of the tumor suppressive function [54].